Nanobodies that neutralize SARS-CoV-2

November 05, 2020

Two separate studies have identified nanobodies - which could be produced less expensively than monoclonal antibodies - that bind tightly to the SARS-CoV-2 spike protein and efficiently neutralize SARS-CoV-2 in cells. "The combined stability, potency, and diverse epitope engagement of our ... nanobodies ... provide a unique potential prophylactic and therapeutic strategy to limit the continued toll of the COVID-19 pandemic," write authors on one paper (Michael Schoof et al.) In the battle against COVID-19, monoclonal antibodies that bind to the spike protein of the SARS-CoV-2 virus are being explored as potential therapeutics. These show promise but must be produced in mammalian cells and need to be delivered intravenously. By contrast, single-domain antibodies called nanobodies can be produced in bacteria or yeast and their stability gives the potential for aerosol delivery. In two separate studies, Michael Schoof et al. and Yufei Xiang et al. describe the identification of nanobodies that efficiently neutralize SARS-CoV-2. Schoof and colleagues screened a yeast surface display of synthetic nanobodies, while Xiang and colleagues screened anti-spike nanobodies produced by a llama. Both papers describe nanobodies that bind tightly to the spike and efficiently neutralize SARS-CoV-2 in cells. Xiang et al note that thermostable nanobodies they developed can be rapidly produced in bulk from microbes. "We envision that the nanobody technology described here will contribute to curbing the current pandemic and possibly a future event," they say.

American Association for the Advancement of Science

Related Yeast Articles from Brightsurf:

Psychedelic compound from magic mushrooms produced in yeast
Scientists from DTU Biosustain prove that psilocybin, a potential drug for treating depression and other psychological conditions can be produced in yeast.

Understanding probiotic yeast
Researchers led by Prof. Johan Thevelein (VIB-KU Leuven Center for Microbiology) have discovered that Saccharomyces boulardii, a yeast with probiotic properties, produces uniquely excessive amounts of acetic acid, the main component of vinegar.

Screening for genes to improve protein production in yeast
By silencing genes, researchers have managed to increase protein production in yeast significantly.

Modern beer yeast emerged from mix of European grape wine, Asian rice wine yeast
For thousands of years brewers made beer using specialized strains of the budding yeast Saccharomyces cerevisiae.

Anticancer mechanism revealed in yeast experiments
Scientists uncover how important enzymes in both fission yeast and human cancer cells interact to boost cell proliferation.

Getting yeast to make artificial sweets
The holiday season can be a time of excess, but low- or no-calorie sweeteners could help merry-makers stay trim.

Solar panels for yeast cell biofactories
In a study in Science, a multidisciplinary team led by Core Faculty member Neel Joshi and Postdoctoral Fellows Junling Guo and Miguel Suástegui at Harvard's Wyss Institute for Biologically Inspired Engineering and John A.

How yeast cells detect genetic infections
ETH researchers studying yeast cells have discovered a surprisingly located new mechanism for detecting foreign genetic material -- whether from pathogens or environmental contamination -- and rendering it harmless.

Yeast species used in food industry causes disease in humans
A major cause of drug-resistant clinical yeast infections is the same species previously regarded as non-pathogenic and commonly used in the biotechnology and food industries.

Yeast can be engineered to create protein pharmaceuticals
It took several years, but a research team headed by Professor Jens Nielsen at Chalmers University of Technology has finally succeeded in mapping out the complex metabolism of yeast cells.

Read More: Yeast News and Yeast Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to